(Q34172333)

31 July 2017

Systemic symptoms without erythema migrans as the presenting picture of early Lyme disease (English)

1 reference

31 July 2017

0 references

1

Allen C Steere

1 reference

31 July 2017

Alpana Dhar

2

1 reference

31 July 2017

Jesus Hernandez

3

1 reference

31 July 2017

Peter A Fischer

4

1 reference

31 July 2017

Vijay K Sikand

5

1 reference

31 July 2017

Robert T Schoen

6

1 reference

31 July 2017

John Nowakowski

7

1 reference

31 July 2017

Gail McHugh

8

1 reference

31 July 2017

David H Persing

9

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

American Journal of Medicine

31 July 2017

1 reference

31 July 2017

114

1 reference

31 July 2017

1

1 reference

31 July 2017

58-62

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

31 July 2017

1 reference

Human granulocytic ehrlichiosis: a case series from a medical center in New York State

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Direct cultivation of the causative agent of human granulocytic ehrlichiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Reorganization of genera in the families Rickettsiaceae and Anaplasmataceae in the order Rickettsiales: unification of some species of Ehrlichia with Anaplasma, Cowdria with Ehrlichia and Ehrlichia with Neorickettsia, descriptions of six new species

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Human babesiosis on Nantucket Island. Evidence for self-limited and subclinical infections

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Human Babesiosis on Nantucket Island, USA: Description of the Vector, Ixodes (Ixodes) Dammini, N. Sp. (Acarina: Ixodidae)1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Positive Lyme disease serology in patients with clinical and laboratory evidence of human granulocytic ehrlichiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Antibody Response in Lyme Disease: Evaluation of Diagnostic Tests

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Western blotting in the serodiagnosis of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Vaccination against Lyme disease with recombinant Borrelia burgdorferi outer-surface lipoprotein A with adjuvant. Lyme Disease Vaccine Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Persistent parasitemia after acute babesiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Infection with a babesia-like organism in northern California

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

The early clinical manifestations of Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Amoxycillin plus probenecid versus doxycycline for treatment of erythema migrans borreliosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Treatment of early lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Practice guidelines for the treatment of Lyme disease. The Infectious Diseases Society of America

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Atovaquone and azithromycin for the treatment of babesiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2802%2901440-7

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0002-9343(02)01440-7

1 reference

31 July 2017

1 reference